NCT00782067 Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia Status COMPLETED Phase PHASE2
NCT00781105 Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT00776009 Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. Status COMPLETED Phase PHASE4
NCT00774020 Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB) Status COMPLETED Phase PHASE4
NCT00770965 Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT00770601 Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease Status TERMINATED Phase PHASE3
NCT00768040 Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema Status TERMINATED Phase PHASE2
NCT00760877 Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR) Status COMPLETED Phase PHASE3
NCT00758524 A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension Status COMPLETED Phase PHASE2
NCT00757757 A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases Status TERMINATED Phase PHASE1/PHASE2
NCT00756509 Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib Status COMPLETED Phase PHASE4
NCT00756340 A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT00751608 Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients Status WITHDRAWN Phase PHASE2
NCT00751036 Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg Status TERMINATED Phase PHASE3
NCT00750295 A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis Status COMPLETED Phase PHASE1/PHASE2
NCT00749372 MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions Status COMPLETED Phase NA
NCT00748189 Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE3
NCT00745485 Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid Status COMPLETED Phase PHASE4